These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome. Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637 [TBL] [Abstract][Full Text] [Related]
3. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX. Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709 [TBL] [Abstract][Full Text] [Related]
4. Atypical fibroxanthoma presenting immunoreactivity against CD10 and CD99. Nakamura Y; Abe Y; Ichimiya M; Muto M J Dermatol; 2010 Apr; 37(4):387-9. PubMed ID: 20507414 [No Abstract] [Full Text] [Related]
5. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Soleymani T; Tyler Hollmig S Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020 [TBL] [Abstract][Full Text] [Related]
6. Atypical Fibroxanthoma: A case series and review of literature. Mahalingam S; Shah A; Stewart A Auris Nasus Larynx; 2015 Dec; 42(6):469-71. PubMed ID: 25912604 [TBL] [Abstract][Full Text] [Related]
7. Atypical fibroxanthoma--a retrospective immunohistochemical study of 42 cases. Singh M; Mann R; Ilankovan V; Hussein K; D'arrigo C J Oral Maxillofac Surg; 2012 Nov; 70(11):2713-8. PubMed ID: 22494510 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. de Feraudy S; Mar N; McCalmont TH Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147 [TBL] [Abstract][Full Text] [Related]
9. Oral undifferentiated high-grade pleomorphic sarcoma: report of a case. Alfredo E; de Pádua JM; Vicentini EL; Marchesan MA; Comelli Lia RC; da Cruz Perez DE; Silva-Sousa YT Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e37-40. PubMed ID: 18155600 [TBL] [Abstract][Full Text] [Related]
16. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum. Chen SX; Eichenfield DZ; Orme C; Hinds B Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146 [TBL] [Abstract][Full Text] [Related]
17. Clear cell atypical fibroxanthoma:a clinicopathologic study. Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470 [TBL] [Abstract][Full Text] [Related]
18. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma. Miller K; Goodlad JR; Brenn T Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760 [TBL] [Abstract][Full Text] [Related]
19. The many faces of Atypical fibroxanthoma. Agaimy A Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163 [TBL] [Abstract][Full Text] [Related]